[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:54:26+00:00",
    "headline": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
    "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
    "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
      "content": {
        "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
        "contentType": "STORY",
        "title": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
        "pubDate": "2026-02-03T01:54:26Z",
        "displayTime": "2026-02-03T01:54:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1",
          "originalWidth": 949,
          "originalHeight": 505,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qbitK_60Vc8oncBc9nQEQw--~B/aD01MDU7dz05NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 949,
              "height": 505,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtjhuWw_GHJ65_98O46.rg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CCCC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:08:48+00:00",
    "headline": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
    "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
    "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
      "content": {
        "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
        "contentType": "STORY",
        "title": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
        "description": "",
        "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
        "pubDate": "2026-02-03T01:08:48Z",
        "displayTime": "2026-02-03T01:08:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T00:32:25+00:00",
    "headline": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
    "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
      "content": {
        "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
        "contentType": "STORY",
        "title": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
        "pubDate": "2026-02-03T00:32:25Z",
        "displayTime": "2026-02-03T00:32:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2",
          "originalWidth": 749,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iLXPnbLixgbu7HLg88EG3A--~B/aD02MDA7dz03NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 749,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FUe6qiNfEaOYihq26Oq6OQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACHV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T08:39:08+00:00",
    "headline": "Stocks to Watch Tuesday: Palantir, Teradyne, AMD",
    "summary": "↗️ Palantir (PLTR): The data company reported higher-than-expected earnings, as strong demand for its AI technology fueled another quarter of record revenue. Palantir stock jumped 5% in offhours trading.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
      "content": {
        "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: Palantir, Teradyne, AMD",
        "description": "",
        "summary": "↗️ Palantir (PLTR): The data company reported higher-than-expected earnings, as strong demand for its AI technology fueled another quarter of record revenue. Palantir stock jumped 5% in offhours trading.",
        "pubDate": "2026-02-03T08:39:08Z",
        "displayTime": "2026-02-03T08:39:08Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9234fa62-b0cf-3ed2-ba67-8ebb3210dc74/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/007TBBbPiTfDjleSwZDKyg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OcdPBlat2RDzV7EuOEo3wA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "PEP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T08:01:46+00:00",
    "headline": "Big Tech and Pharma Earnings: What to Watch This Week",
    "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
      "content": {
        "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
        "contentType": "STORY",
        "title": "Big Tech and Pharma Earnings: What to Watch This Week",
        "description": "",
        "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
        "pubDate": "2026-02-03T08:01:46Z",
        "displayTime": "2026-02-03T08:01:46Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/438e74ab-57b8-37a1-bea0-98d968b92710/big-tech-and-pharma-earnings-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrpLbN9EPkBkY5Q7DEqcow--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6T87T9eSRa4Fs4LKL4AqeA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T10:25:00+00:00",
    "headline": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More",
    "summary": "Stock futures were rising Tuesday as Palantir’s strong earnings injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 10% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
    "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
      "content": {
        "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
        "contentType": "STORY",
        "title": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More",
        "description": "",
        "summary": "Stock futures were rising Tuesday as Palantir’s strong earnings injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 10% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
        "pubDate": "2026-02-03T10:25:00Z",
        "displayTime": "2026-02-03T10:25:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e9fc8b56-cb47-3ea3-b443-ba365c4733a4/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UEXjlWQWU_hzKOejLcC4Zw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s4TWX16tW1HmSVkBOJ5DTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NXPI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T10:12:01+00:00",
    "headline": "Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure",
    "summary": "Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral rating and $26 price target on Pfizer Inc. (NYSE:PFE), citing the pharma giant’s key hurdles. Pfizer is facing the first of three years of rising patent-cliff strain on its profit margins, as its business […]",
    "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6d5757bb-d8c9-3b06-8677-e6d5f7f12df7",
      "content": {
        "id": "6d5757bb-d8c9-3b06-8677-e6d5f7f12df7",
        "contentType": "STORY",
        "title": "Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral rating and $26 price target on Pfizer Inc. (NYSE:PFE), citing the pharma giant’s key hurdles. Pfizer is facing the first of three years of rising patent-cliff strain on its profit margins, as its business […]",
        "pubDate": "2026-02-03T10:12:01Z",
        "displayTime": "2026-02-03T10:12:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca",
          "originalWidth": 800,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6WTGkeph75pOVhavnybpiw--~B/aD00ODA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 800,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DK4Jv.eKjvFvm3Ar9OASuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:20:43+00:00",
    "headline": "Tech Bulls Rule Equities Pre-Bell; Asia Surges, Europe Gains",
    "summary": "Wall Street futures pointed moderately higher pre-bell Tuesday, following record-breaking rallies ov",
    "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "b5ae9073-06f9-3e42-a226-c0542f0e5087",
      "content": {
        "id": "b5ae9073-06f9-3e42-a226-c0542f0e5087",
        "contentType": "STORY",
        "title": "Tech Bulls Rule Equities Pre-Bell; Asia Surges, Europe Gains",
        "description": "",
        "summary": "Wall Street futures pointed moderately higher pre-bell Tuesday, following record-breaking rallies ov",
        "pubDate": "2026-02-03T11:20:43Z",
        "displayTime": "2026-02-03T11:20:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PLTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]